1. Home
  2. NMFC vs PLSE Comparison

NMFC vs PLSE Comparison

Compare NMFC & PLSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NMFC
  • PLSE
  • Stock Information
  • Founded
  • NMFC 2010
  • PLSE 2014
  • Country
  • NMFC United States
  • PLSE United States
  • Employees
  • NMFC N/A
  • PLSE N/A
  • Industry
  • NMFC Finance/Investors Services
  • PLSE Medical/Dental Instruments
  • Sector
  • NMFC Finance
  • PLSE Health Care
  • Exchange
  • NMFC Nasdaq
  • PLSE Nasdaq
  • Market Cap
  • NMFC 1.2B
  • PLSE 1.1B
  • IPO Year
  • NMFC 2011
  • PLSE 2016
  • Fundamental
  • Price
  • NMFC $11.38
  • PLSE $19.58
  • Analyst Decision
  • NMFC Hold
  • PLSE
  • Analyst Count
  • NMFC 2
  • PLSE 0
  • Target Price
  • NMFC $11.50
  • PLSE N/A
  • AVG Volume (30 Days)
  • NMFC 538.4K
  • PLSE 137.8K
  • Earning Date
  • NMFC 02-24-2025
  • PLSE 10-30-2024
  • Dividend Yield
  • NMFC 11.23%
  • PLSE N/A
  • EPS Growth
  • NMFC N/A
  • PLSE N/A
  • EPS
  • NMFC 1.04
  • PLSE N/A
  • Revenue
  • NMFC $373,513,000.00
  • PLSE N/A
  • Revenue This Year
  • NMFC $1.68
  • PLSE N/A
  • Revenue Next Year
  • NMFC N/A
  • PLSE N/A
  • P/E Ratio
  • NMFC $10.95
  • PLSE N/A
  • Revenue Growth
  • NMFC 4.95
  • PLSE N/A
  • 52 Week Low
  • NMFC $10.62
  • PLSE $6.60
  • 52 Week High
  • NMFC $13.10
  • PLSE $22.69
  • Technical
  • Relative Strength Index (RSI)
  • NMFC 54.76
  • PLSE 58.17
  • Support Level
  • NMFC $10.80
  • PLSE $17.18
  • Resistance Level
  • NMFC $11.43
  • PLSE $18.72
  • Average True Range (ATR)
  • NMFC 0.15
  • PLSE 1.10
  • MACD
  • NMFC 0.04
  • PLSE 0.03
  • Stochastic Oscillator
  • NMFC 92.06
  • PLSE 79.66

About NMFC New Mountain Finance Corporation

New Mountain Finance Corp is a closed-end, non-diversified management investment company. It invests in equity interests such as preferred stock, common stock, warrants, or options received in connection with debt investments or may include direct investment in the equity of private companies. The company's investment objective is to generate current income and capital appreciation through sourcing and origination of debt securities at all levels of the capital structure, including first and second-lien debt, notes, bonds, and mezzanine securities.

About PLSE Pulse Biosciences Inc (DE)

Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled. Substantial revenue is generated from North America Majorly due to the sale of systems.

Share on Social Networks: